Page last updated: 2024-08-21

ethylnitrosourea and BH4 Deficiency

ethylnitrosourea has been researched along with BH4 Deficiency in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, TM; Safos, S1
Blain, F; Chang, TM; Heft, R; Peevers, R; Sarkissian, CN; Scriver, CR; Shao, Z; Su, H1
Bode, VC; Dove, WF; McDonald, JD; Shedlovsky, A1

Other Studies

3 other study(ies) available for ethylnitrosourea and BH4 Deficiency

ArticleYear
Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report.
    Artificial cells, blood substitutes, and immobilization biotechnology, 1995, Volume: 23, Issue:6

    Topics: Administration, Oral; Animals; Collodion; Drug Compounding; Ethylnitrosourea; Feasibility Studies; Fungal Proteins; Humans; Mice; Mice, Mutant Strains; Mutagenesis; Phenylalanine Ammonia-Lyase; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Rhodotorula; Species Specificity

1995
A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Mar-02, Volume: 96, Issue:5

    Topics: Animals; Basidiomycota; Cloning, Molecular; Disease Models, Animal; Escherichia coli; Ethylnitrosourea; Humans; Injections, Intraperitoneal; Mice; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylketonurias; Recombinant Proteins

1999
The use of N-ethyl-N-nitrosourea to produce mouse models for human phenylketonuria and hyperphenylalaninemia.
    Progress in clinical and biological research, 1990, Volume: 340C

    Topics: Amino Acid Metabolism, Inborn Errors; Animals; Crosses, Genetic; Disease Models, Animal; Ethylnitrosourea; Female; Humans; Male; Mice; Mice, Mutant Strains; Mutation; Phenotype; Phenylalanine; Phenylketonurias

1990